Recorded March 16, 2022 | On-Demand Webinar
Learn the statutory definitions of a biological product as well as recognize the distinctions that drive jurisdiction and regulatory pathways. Understand pathways to market and how to determine which pathway to choose. Understand the applicability of both the PHS Act and the FDCA to biological products.
This session was recorded as part of FDLI’s virtual course, "Introduction to Biological Products, Including Vaccines, Biosimilars, Cell and Gene Therapies, and Other Advanced Therapies" in March 2022.